Quality of Life and Depression in Rheumatoid Arthritis Patients Treated with Biologics – A Single Centre Experience

Wojciech Tański,1 Adrianna Szalonka,2 Beata Tomasiewicz1 1Department of Internal Medicine, 4th Military Teaching Hospital, Wroclaw, Poland; 2Centre for Research and Innovation, 4th Military Teaching Hospital, Wroclaw, PolandCorrespondence: Wojciech Tański, Department of Interna...

Full description

Bibliographic Details
Main Authors: Tański W, Szalonka A, Tomasiewicz B
Format: Article
Language:English
Published: Dove Medical Press 2022-03-01
Series:Psychology Research and Behavior Management
Subjects:
Online Access:https://www.dovepress.com/quality-of-life-and-depression-in-rheumatoid-arthritis-patients-treate-peer-reviewed-fulltext-article-PRBM
_version_ 1818492292790484992
author Tański W
Szalonka A
Tomasiewicz B
author_facet Tański W
Szalonka A
Tomasiewicz B
author_sort Tański W
collection DOAJ
description Wojciech Ta&nacute;ski,1 Adrianna Szalonka,2 Beata Tomasiewicz1 1Department of Internal Medicine, 4th Military Teaching Hospital, Wroclaw, Poland; 2Centre for Research and Innovation, 4th Military Teaching Hospital, Wroclaw, PolandCorrespondence: Wojciech Ta&nacute;ski, Department of Internal Medicine, 4th Military Teaching Hospital, Weigla 5, Wroclaw, 50-981, Poland, Email dr.wojciech.tanski@gmail.comIntroduction: Patients with rheumatoid arthritis (RA) often experience depression, which has a very negative impact on the assessment of the quality of life (QoL). However, there are not many studies that assess the relationship between depression and QoL in RA patients. The aim of the study was to assess the level of QoL and determine the mutual relationship between anxiety and depression levels and QoL in patients treated for RA.Material and Methods: The study included 101 patients (aged:52.4± 16.97), who met the established criteria for a diagnosis of RA and treatment with a biological agent. Only standardized tools were used to examine the patients: WHO-QoL, HADS and the VAS scale.Results: The mean RA duration in the group studied was 13.54± 9.51 years and the disease activity score was 4.8± 0.8. The mean QoL perception score was 3.48± 0.8. Nearly 40% of the respondents could not clearly determine their QoL, perceiving it as neither poor nor good, and 10% believed their QoL is poor or very poor. The correlation analysis revealed that anxiety is significantly and negatively associated with QoL in the psychological domain (r = − 0.472, p < 0.001) and social domain (r = − 0.298, p = 0.023) and depression is significantly and negatively associated with QoL in the psychological domain (r = − 0.322, p = 0.01) and physical health domain (r = − 0.209, p = 0.04). In the multiple linear regression model, depression was an independent negative predictor affecting the following domains: perception of QoL and perception of health, and physical health.Conclusion: RA patients treated with biologics present a low level of health perception and an average level of QoL perception. Depression and anxiety negatively correlate with QoL domains: the higher the anxiety and depression levels, the poorer the QoL in the psychological and social relationships domains. Depression is an independent determinant of decreased QoL.Keywords: rheumatoid arthritis, quality of life, depression, anxiety, predictors
first_indexed 2024-12-10T17:41:07Z
format Article
id doaj.art-2e259e6d26fd4ac190e7f83fbf3326ff
institution Directory Open Access Journal
issn 1179-1578
language English
last_indexed 2024-12-10T17:41:07Z
publishDate 2022-03-01
publisher Dove Medical Press
record_format Article
series Psychology Research and Behavior Management
spelling doaj.art-2e259e6d26fd4ac190e7f83fbf3326ff2022-12-22T01:39:22ZengDove Medical PressPsychology Research and Behavior Management1179-15782022-03-01Volume 1549150173385Quality of Life and Depression in Rheumatoid Arthritis Patients Treated with Biologics &ndash; A Single Centre ExperienceTański WSzalonka ATomasiewicz BWojciech Ta&nacute;ski,1 Adrianna Szalonka,2 Beata Tomasiewicz1 1Department of Internal Medicine, 4th Military Teaching Hospital, Wroclaw, Poland; 2Centre for Research and Innovation, 4th Military Teaching Hospital, Wroclaw, PolandCorrespondence: Wojciech Ta&nacute;ski, Department of Internal Medicine, 4th Military Teaching Hospital, Weigla 5, Wroclaw, 50-981, Poland, Email dr.wojciech.tanski@gmail.comIntroduction: Patients with rheumatoid arthritis (RA) often experience depression, which has a very negative impact on the assessment of the quality of life (QoL). However, there are not many studies that assess the relationship between depression and QoL in RA patients. The aim of the study was to assess the level of QoL and determine the mutual relationship between anxiety and depression levels and QoL in patients treated for RA.Material and Methods: The study included 101 patients (aged:52.4± 16.97), who met the established criteria for a diagnosis of RA and treatment with a biological agent. Only standardized tools were used to examine the patients: WHO-QoL, HADS and the VAS scale.Results: The mean RA duration in the group studied was 13.54± 9.51 years and the disease activity score was 4.8± 0.8. The mean QoL perception score was 3.48± 0.8. Nearly 40% of the respondents could not clearly determine their QoL, perceiving it as neither poor nor good, and 10% believed their QoL is poor or very poor. The correlation analysis revealed that anxiety is significantly and negatively associated with QoL in the psychological domain (r = − 0.472, p < 0.001) and social domain (r = − 0.298, p = 0.023) and depression is significantly and negatively associated with QoL in the psychological domain (r = − 0.322, p = 0.01) and physical health domain (r = − 0.209, p = 0.04). In the multiple linear regression model, depression was an independent negative predictor affecting the following domains: perception of QoL and perception of health, and physical health.Conclusion: RA patients treated with biologics present a low level of health perception and an average level of QoL perception. Depression and anxiety negatively correlate with QoL domains: the higher the anxiety and depression levels, the poorer the QoL in the psychological and social relationships domains. Depression is an independent determinant of decreased QoL.Keywords: rheumatoid arthritis, quality of life, depression, anxiety, predictorshttps://www.dovepress.com/quality-of-life-and-depression-in-rheumatoid-arthritis-patients-treate-peer-reviewed-fulltext-article-PRBMrheumatoid arthritisquality of lifedepressionanxietypredictors
spellingShingle Tański W
Szalonka A
Tomasiewicz B
Quality of Life and Depression in Rheumatoid Arthritis Patients Treated with Biologics &ndash; A Single Centre Experience
Psychology Research and Behavior Management
rheumatoid arthritis
quality of life
depression
anxiety
predictors
title Quality of Life and Depression in Rheumatoid Arthritis Patients Treated with Biologics &ndash; A Single Centre Experience
title_full Quality of Life and Depression in Rheumatoid Arthritis Patients Treated with Biologics &ndash; A Single Centre Experience
title_fullStr Quality of Life and Depression in Rheumatoid Arthritis Patients Treated with Biologics &ndash; A Single Centre Experience
title_full_unstemmed Quality of Life and Depression in Rheumatoid Arthritis Patients Treated with Biologics &ndash; A Single Centre Experience
title_short Quality of Life and Depression in Rheumatoid Arthritis Patients Treated with Biologics &ndash; A Single Centre Experience
title_sort quality of life and depression in rheumatoid arthritis patients treated with biologics ndash a single centre experience
topic rheumatoid arthritis
quality of life
depression
anxiety
predictors
url https://www.dovepress.com/quality-of-life-and-depression-in-rheumatoid-arthritis-patients-treate-peer-reviewed-fulltext-article-PRBM
work_keys_str_mv AT tanskiw qualityoflifeanddepressioninrheumatoidarthritispatientstreatedwithbiologicsndashasinglecentreexperience
AT szalonkaa qualityoflifeanddepressioninrheumatoidarthritispatientstreatedwithbiologicsndashasinglecentreexperience
AT tomasiewiczb qualityoflifeanddepressioninrheumatoidarthritispatientstreatedwithbiologicsndashasinglecentreexperience